There are no known interactions that would prevent combining it with standard sports nutrition products
[DOI] [PMC free article] [PubMed] [Google Scholar] 81.Lu SC, Chen M, Atangan L, et al
Notably, semaglutide emerged as the second best-selling drug in 2024, and in the same year, sales of tirzepatide increased 124% from the previous year [2]
doi: 10.3389/fimmu.2025.1536569 Received 29 November 2024 Accepted 27 January 2025 Published 17 February 2025 Volume 16 - 2025 Edited by Stergios Boussios, Canterbury Christ Church University, United Kingdom Reviewed by Xiaohong Tan, Bowling Green State University, United States Lai Jiang, Zhejiang Chinese Medical University, China Updates Copyright 2025 Mathavan, Tam, Mustaffa and Tye